Efficacy and safety of low-dose pioglitazone after primary coronary angioplasty with the use of bare metal stent in patients with acute myocardial infarction and with type 2 diabetes mellitus or impaired glucose tolerance-Reference-Cited by-同舟云学术

Efficacy and safety of low-dose pioglitazone after primary coronary angioplasty with the use of bare metal stent in patients with acute myocardial infarction and with type 2 diabetes mellitus or impaired glucose tolerance

Published:2007-05-21 Issue:3 Volume:22 Page:146-151
ISSN:0910-8327
Container-title:Heart and Vessels
language:en
Short-container-title:Heart Vessels

Author:

Yokoyama Jin,Sutoh Naoyuki,Higuma Takumi,Horiuchi Daisuke,Katoh Chisato,Yokota Takashi,Echizen Takashi,Sasaki Shingo,Hanada Hiroyuki,Osanai Tomohiro,Okumura Ken

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00380-006-0951-z.pdf

Reference22 articles.

1. A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease

2. Restenosis after Arterial Injury Caused by Coronary Stenting in Patients with Diabetes Mellitus

3. Three-year clinical follow-up after Palmaz-Schatz stenting

4. Predictive Factors of Restenosis After Coronary Stent Placement

5. Midterm angiographic outcome of single-vessel intracoronary stent placement in diabetic versus nondiabetic patients: A matched comparative study

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus;Cochrane Database of Systematic Reviews;2020-11-19

2. Effects of antidiabetic drugs on left ventricular function/dysfunction: a systematic review and network meta-analysis;Cardiovascular Diabetology;2020-01-22

3. Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus;COCHRANE DB SYST REV;2020

4. Effect of Pioglitazone in Preventing In-Stent Restenosis after Percutaneous Coronary Intervention in Patients with Type 2 Diabetes: A Meta-Analysis;PLOS ONE;2016-05-10

5. Pioglitazone treatment and cardiovascular event and death in subjects with type 2 diabetes without established cardiovascular disease (JDDM 36);Diabetes Research and Clinical Practice;2015-09